Agency: Food and Drug Administration
Pages: 1
[FR Doc C0-28133] 1. Biological Products: Reporting of Biological Product Deviations in
Correction
In rule document 0028133 beginning on page 66621 in the issue of Tuesday, November 7, 2000, make the following correction:
On page 66622, in the first column, in the DATES section, ``May 7, 2000'' should read ``May 7, 2001''.
[FR Doc. C028133 Filed 11800; 8:45 am]
Published: 2000-11-09 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc C0-27735] 2. Irradiation in the Production, Processing and Handling of Food
Correction
In rule document 0027735 beginning on page 64605 in the issue of
Monday, October 30, 2000, the docket number is corrected to read as set forth above.
[FR Doc. C027735 Filed 11800; 8:45 am]
BILLING CODE 150501D
Published: 2000-11-09 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc 00-28851] 3. Agency Information Collection Activities; Submission for OMB Review; Comment
The Food and Drug Administration (FDA) is announcing that the proposed collection of information listed below has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Published: 2000-11-09 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc 00-28852] 4. Agency Information Collection Activities; Submission for OMB Review; Comment
The Food and Drug Administration (FDA) is announcing that the proposed collection of information listed below has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Published: 2000-11-09 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc 00-28694] 5. Radiological Health Reengineering; Public Workshop
The Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH), is announcing a public workshop intended to gather information regarding its radiological health programs. The topic to be discussed is reengineering of electronic product radiation control processes with attention to prioritization, information exchange
Published: 2000-11-09 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc 00-28776] 6. Draft Guidance for Industry on Cancer Drug and Biological Products--Clinical
The Food and Drug Administration (FDA) is announcing the [[Page 67390]]
availability of a draft guidance for industry entitled ``Cancer Drug
and Biological ProductsClinical Data in Marketing Applications.'' The
draft guidance document provides recommendations for sponsors designing
clinical trials to demonstrate the safety and efficacy of cancer
Published: 2000-11-09 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
Pages: 1